Latest Financial Position News

Carnaby Resources reports strong September quarter progress, including significant high-grade copper-gold drill results, full JV buyout, and a $12.5 million placement to advance its Greater Duchess project.

Bounty Oil & Gas reported a modest $272,000 in oil revenue for Q3 2025, boosted reserves in Queensland, and plans to restart Surat Basin production in 2026 while navigating ongoing legal challenges offshore Sydney.

Constellation Resources advances its exploration in Western Australia with encouraging natural hydrogen and copper-gold findings, supported by CSIRO studies and a $2.1 million capital raise.

Verity Resources reports robust Phase 1 drilling results at its Monument Gold Project, secures full ownership of Botswana copper-silver assets, and confirms significant rare earth mineralisation in Brazil, underpinning its growth strategy.

NewPeak Metals has completed acquisition of 100% ownership of the Las Opeñas exploration permits in Argentina, with drilling scheduled for early 2026. The company also advances drilling preparations at its Tansey Gold Project in Australia, supported by strong insider buying.

Larvotto Resources has greenlit the Hillgrove Antimony-Gold Project development, securing $175 million in funding and reporting strong high-grade drilling results that bolster its resource base.

Tasman Resources has progressed its exploration efforts at Lake Torrens and Parkinson Dam projects, backed by a recent $850,000 capital raise and strategic board changes.

Anagenics Limited reports a notable improvement in operating cash outflows for 1Q26, driven by cost efficiencies and strong brand performance, with Bouf Haircare on track to exceed $9 million in sales.

Peregrine Gold has identified large-scale, high-grade iron ore deposits at its Newman project and expanded gold anomalies at Tin Can and Epithermal prospects, backed by a $3 million capital raise.

Austral Gold’s Q3 report reveals a sharp production drop at Guanaco following a fatal accident, prompting a downward revision of 2025 output and cost hikes, while Casposo’s refurbishment signals a new growth phase.

Argenica Therapeutics reports ARG-007 is safe in acute ischemic stroke patients and shows promising efficacy signals in a high-risk subgroup, paving the way for a focused Phase 2b trial.

West Cobar Metals reports significant progress across its WA and NSW projects, with promising assay results for rare earths and base metals, alongside strategic engagement in the US market and a recent $1.25 million capital raise.